Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical TechnologiesNSE:AAKAAR -2.94%20 3-Year ROIIC % is 11.97 as of Mar. 2026, which is 20% below its 10-year median of 15.03. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks better than 63.02% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Aakaar Medical Technologies's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 11.97%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Aakaar Medical Technologies's 3-Year ROIIC % or its related term are showing as below:
NSE:AAKAAR's 3-Year ROIIC % is ranked better than 63.02% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.57
vs NSE:AAKAAR: 11.97
Aakaar Medical Technologies (NSE:AAKAAR) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Aakaar Medical Technologies 3-Year ROIIC % Related Terms
Aakaar Medical Technologies 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:AAKAAR vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Aakaar Medical Technologies's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aakaar Medical Technologies 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Aakaar Medical Technologies's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Aakaar Medical Technologies (NSE:AAKAAR) has a 3-Year ROIIC % of 11.97 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aakaar Medical Technologies and its competitors. This is 20% below median its historical median of 15.03. Over the past decade, Aakaar Medical Technologies' 3-Year ROIIC % has ranged from 11.97 to 18.08. According to the industry distribution chart, Aakaar Medical Technologies ranks #294 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 37%.
Is Aakaar Medical Technologies' 3-Year ROIIC % too high?
Aakaar Medical Technologies' current 3-Year ROIIC % of 11.97 is 20% below median its 10-year median of 15.03. Over the past 10 years, this metric has ranged from a low of 11.97 to a high of 18.08. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.57. Aakaar Medical Technologies' value of 11.97 is 662.4% above this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #294 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #294 out of 795 companies for 3-Year ROIIC %. This puts Aakaar Medical Technologies in the upper half of its industry. The industry median 3-Year ROIIC % is 1.57. Aakaar Medical Technologies' value of 11.97 is 662.4% above this benchmark. Historically, Aakaar Medical Technologies' own 3-Year ROIIC % has ranged from 11.97 to 18.08 over the past decade. While the company's 10-year median is 15.03 vs. the industry median of 1.57, Aakaar Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.57, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current 3-Year ROIIC % of 11.97 is 662.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current 3-Year ROIIC % is 11.97, which is 20% below median its own 10-year median of 15.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current 3-Year ROIIC % of 11.97. The current 3-Year ROIIC % is 11.97, which is 20% below median its 10-year median of 15.03 and 662.4% above the Medical Devices & Instruments industry median of 1.57. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current 3-Year ROIIC % is 11.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score
Get the complete analysis for NSE:AAKAAR
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
